Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06377527 · ClinicalTrials.gov registry record
Establishing a Tumor Registry of Patients With Mesonephric-like Adenocarcinoma (MLA)
A clinical trial of Mesonephric-like Adenocarcinoma, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT06377527 is a study of Mesonephric-like Adenocarcinoma that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 2,000 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06377527, a study of Mesonephric-like Adenocarcinoma, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
To develop a database of medical information about patients with MLA in an effort to increase our understanding of the characteristics of MLA, which is the rarest form of endometrial carcinoma.
Conditions Studied
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2024-07-10 |
| Est. Completion | 2037-12-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06377527
The ClinicalTrials.gov registry entry for NCT06377527 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Mesonephric-like Adenocarcinoma appearing as the primary indexed condition, and to 0 interventions.
NCT06377527 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06377527 about?
NCT06377527 is a clinical study titled "Establishing a Tumor Registry of Patients With Mesonephric-like Adenocarcinoma (MLA)". To develop a database of medical information about patients with MLA in an effort to increase our understanding of the characteristics of MLA, which is the rarest form of endometrial carcinoma.
What is the current status of trial NCT06377527?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2024-07-10. Estimated completion is 2037-12-28.
What conditions does trial NCT06377527 study?
This clinical trial studies the following conditions: Mesonephric-like Adenocarcinoma.
Who is sponsoring clinical trial NCT06377527?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06377527 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.